Meridian Bioscience Europe SA

Meridian Bioscience Europe reported total assets of 617,765 € at the end of the 2025 financial year (annual accounts filed with the NBB on 23 Jun 2026).

By total assets for 2025, Meridian Bioscience Europe ranks in the top half of the 327 companies in its sector (NACE 2110) in Belgium that filed accounts for that financial year. Largest companies in the sector →

Company number (CBE) 0408.081.968 · VAT BE0408081968
1420 Braine-l'Alleud
active in Manufacture of basic pharmaceutical products (NACE 21100)
operating since 08 Feb 1971 (≈ 55 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Meridian Bioscience Europe shows with a free account.

See the score
Profile
SA since 1971
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result22,729 €
Equity450,490 €
Cash388,342 €
EBITDA37,402 €
Total assets617,765 €
The line marks its sector median: 38.7% (82 companies).

Change 2022 → 2025: Equity -10 % Total assets -44 %

Accounts of the company itself (not consolidated).

The full file covers 14 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Meridian Bioscience Europe's annual accounts

20252024202320222021
Net result22,729 €
Equity450,490 €
Cash388,342 €
EBITDA37,402 €
Total assets617,765 €

Filed annual accounts

  • Year ended 31 Dec 2025filed on 23 Jun 2026
  • Year ended 31 Dec 2024filed on 07 Jul 2025
  • Year ended 31 Dec 2023filed on 13 May 2024
  • Year ended 30 Sep 2022filed on 09 Feb 2023
  • Year ended 30 Sep 2021filed on 27 Apr 2022

Meridian Bioscience Europe's financial analysis

Management and control of Meridian Bioscience Europe

5 active director(s) in the register.

Meridian Bioscience Europe's shareholders and holdings →

Meridian Bioscience Europe's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0408.081.968
VAT number
BE0408081968
Peppol
Registered · 0208:0408081968 · as of 10 Nov 2026
Legal form
SA
Incorporated
08 Feb 1971
Registered office
1420 Braine-l'Alleud
Latest accounts
2025 · filed on 23 Jun 2026
Activity
Manufacture of basic pharmaceutical products (NACE 21100)

Meridian Bioscience Europe (SA) has been based in Braine-l'Alleud since 1971, active in: manufacture of basic pharmaceutical products. For 2025, it reports a net profit of 22,729 € and equity of 450,490 €; its revenue is not published. Its solvency stands at 72.9%, above the median of its sector (38.7%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Meridian Bioscience Europe

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Meridian Bioscience Europe

What is the revenue of Meridian Bioscience Europe?

Meridian Bioscience Europe files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Meridian Bioscience Europe?

In Belgium, the VAT number is the company number prefixed with BE: BE0408081968 for Meridian Bioscience Europe, if the company is VAT-registered. Its company number (CBE) is 0408.081.968.

Where is the registered office of Meridian Bioscience Europe?

According to the CBE register, the registered office of Meridian Bioscience Europe is in 1420 Braine-l'Alleud.

What is the equity of Meridian Bioscience Europe?

At the close of the 2025 financial year, the equity of Meridian Bioscience Europe amounts to 450,490 €, a solvency of 72.9% of total assets.

Who manages Meridian Bioscience Europe?

The register lists 5 active mandates at Meridian Bioscience Europe. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

How large is Meridian Bioscience Europe within its sector?

By total assets for 2025, Meridian Bioscience Europe ranks in the top half of the 327 companies in its sector (NACE 2110) in Belgium that filed accounts for that financial year.

Idonis

The full file of Meridian Bioscience Europe

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 06 Jul 2026

No credit card, no commitment.

What each plan unlocks →